Introduction {#s1}
============

Head and neck cancer (HNC) remain the primary cause of cancer-related mortality in the world. Oral squamous cell carcinoma (OSCC) is the most important type of HNC, accounting for about 90%, characterized by advanced diagnosis ([@B1]), poor prognosis ([@B2]), low overall survival ([@B3]), and high recurrence ([@B4]). Head and neck cancer (HNC) are regarded as the tenth most common cancer in the world and the seventh most common cause of cancer deaths. There are \~400,000 oral and pharyngeal diseases, 160,000 laryngeal cancers and 300,000 deaths worldwide each year ([@B5]--[@B7]). Head and neck cancer is a common heterogeneous tumor that exists in the oral, pharyngeal, and larynx lesions ([@B8]). Contributing factors may include fewer mutant oncogenes, the presence of extensive p53 and lower levels of tumor hypoxia, but the mechanisms remain to be explored in detail. The development of cancer genomics has been widely used to reveal subgroups of patients with different prognoses and different responses to treatment. However, the phenotype of cancer is defined not only by the intrinsic activity of tumor cells but also by immune cells recruited and attracted in the tumor-associated microenvironment. Until now, the roles of immune cells in the tumor-related microenvironment during tumor development remain unclear.

There is increasing evidence that tumor cell immune cells (TIICs), which including B cells, T cells, dendritic cells, macrophages, neutrophils, monocyte, and mast cells, can regulate cancer progression and stimulate attractive therapeutic targets. In addition, the effect of TIICs on cancer development has been largely documented ([@B9]--[@B12]). In the work, the CIBERSOFT method was applied to define the 22 TICCs subsets of the immune response in HNC in order to examine the mutual relationship with molecular subsets and clinical characteristics. Our findings also revealed distinct immune phenotypes for molecular HNC subclasses. Moreover, the present study provides a novel insight into immunotherapy strategy for HNC.

Materials and Methods {#s2}
=====================

Data Source and Data Processing
-------------------------------

Firstly, the RNA-seq data (FPKM values) of HNC cohort were downloaded from the Cancer Genome Atlas (TCGA) website (<https://cancergenome.nih.gov/>), including four files (gdc_download_20190201_030206.452249.tar.gz, gdc_manifest_20190201_025835.txt, metadata.cart.2019-02-01.json and clinical.cart.2019-02-01.json). Secondly, we merged the data using Perl software (mRNA_merge.pl). RNA-seq profiles were normalized using Voom standardized method (variance modeling at the observational level) ([@B13]).

Quantification of TIICs Using the CIBERSOFT Algorithm
-----------------------------------------------------

The CIBERSOFT method is a gene-based deconvolution algorithm that infers 22 human immune cell types and uses the characteristics of 547 marker genes to quantify the relative scores for each cell type. To enhance the robustness of the results, CIBERSOFT algorithm uses Monte Carlo sampling to derive the deconvoluted P value for each sample. The standardized processed dataset of gene expression is uploaded to the CIBERSOFT website (<https://cibersort.stanford.edu/index.php>), which runs using 1000 aligned default signature matrices ([@B14]).

Total T cells were calculated as a sum of CD8+ T cells, CD4+ naïve T cells, CD4+ memory resting T cells, CD4+ memory activated T cells, follicular helper T cells, regulatory T cells (Tregs), and T cells gamma delta fractions. Total macrophage fraction was imputed as a sum of M0, M1, and M2 macrophage fractions. And total B cells was estimated as a sum of B cells memory and B cells naïve.

Survival Analysis
-----------------

We conducted univariate Cox analysis and Kaplan-Meier survival analysis between LM22 immune cell subsets and OS and screened the prognostic 22 human immune cell phenotypes. The univariate Cox analysis and Kaplan-Meier survival analysis was performed by the survfit function in "survival" package in R software. Then, the multivariate Cox regression analysis was used to further validate prognostic 22 human immune cell phenotypes as prognosis factors. We also explore the association between LM22 immune cell and other clinical information, such as TNM stage, Radiation, Grade, Age, and HPV status.

Identification of Molecular Subclassification
---------------------------------------------

In order to further to explore different TME cell infiltration patterns, a consensus cluster algorithm was applied to determine the number of clusters. The process was conducted using "CancerSubtypes" R-package ([@B15]). To uncover the potential difference in TME cell infiltration models among the clusters, differentially expressed genes (DEGs) and different immune cell types were identified using unpaired Student *t* tests. The data set with \|log2 fold change\| ≥ 0.2 and *P* --value less than 0.05 was considered selection criteria for subsequent analysis.

Functional and Pathway Enrichment Analysis
------------------------------------------

To uncover the potential biological significance of DEGs among TME subtypes, Gene Ontology (GO) Biological Process term and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were conducted using "ClusterProfiler" R package ([@B16]). GO enrichment analysis was based on the threshold of *P*-value \< 0.05 and false discovery rate (FDR) of \< 0.05. Gene Set Variation Analysis (GSVA) was conducted to unveil an overall pathway of gene-set activity score for each sample ([@B17]). The Gene sets using the c2 curated signatures were downloaded from the Molecular Signature Database (MSigDB) of Broad Institute. The significant enrichment pathway was identified based on the \|logFoldChange\| ≥0.2 and adjust *P*-value \< 0.05.

Statistical Analysis
--------------------

Patients with a CIBERSOFT P value less than 0.05 were included in the main study. After the initial screen, eligible samples were divided into two groups: HNC tumor samples and adjacent samples. Immune cell profiles were estimated for each sample. In order to explore the association among 21 immune cell subtypes in three groups, Pearson correlation analysis was calculated using R software. The wilcox.test was employed to test the statistical significance between the two groups. For comparisons of more than two groups, Kruskal-Wallis tests were employed to examine the difference among groups ([@B18]). Cox regression analysis was applied to determine the association between inferred proportions of immune cell types and survival. The log-rank statistic was used to test the differences in OS survival between groups using Kaplan-Meier plots. In the univariate Cox regression analysis, variables with a *P* \< 0.05 were considered as independent prognostic overall survival (OS) factors, and the included prognostic factors were used to build the multivariate Cox regression model for OS. Clinical variables, such as age, sex, HPV status, lymph node metastasis, distant metastasis, grade, and TNM stage, were included in the multivariate Cox regression model. To evaluate the relationship between different immune cell subtypes and response to radiation, the wilcox.test was conducted.

A heatmap was produced with the R package "ComplexHeatmap" ([@B19]). The R package "pROC" was used to visualize operating characteristic (ROC) curves to impute the area under the curve (AUC) and confidence intervals to evaluate the diagnostic accuracy of LM 22 immune cell ([@B20]). Statistical analysis was performed using R-Language (R-project.org) and packages obtained through the Bioconductor project ([www.bioconductor.org](http://www.bioconductor.org)). All *P* values were bilateral and a *P* value of \< 0.05 was considered statistically significant.

Results {#s3}
=======

Overview of Data
----------------

A total of 546 samples, included 44 adjacent samples, and 502 tumor samples, were obtained from the TCGA. After performing CIBERSOFT algorithm, 454 patients (11 normal patients and 443 tumor patients) with a *P* value \< 0.05 was considered in the study, including 41 paracancerous tissue, and 11 paired tumor tissue. Meanwhile, 547 TME corresponding gene expression profiles were also filtered for further analysis.

Profile of TME in HNC and Clinicopathological Characteristics of TME Subtypes
-----------------------------------------------------------------------------

The landscape of TME cell infiltration models and MTE signatures was systematically evaluated by CIBERSOFT algorithm. [Figure 1](#F1){ref-type="fig"} summarizes the findings obtain from the 41 paired tumor samples and 11 paired adjacent samples. Obviously, the proportions of TME cells in HNC varies significantly between both intra- and intergroup. The fraction of total T cells and total B cells were higher in HNC adjacent tissue than tumor tissue. Total Macrophage was mainly observed in the adjacent tissue ([Figure 2](#F2){ref-type="fig"}). We found that T cell follicular helper, T cells CD8, NK cells activated, Monocyte, Macrophages M0, NK cells resting, Mast cells resting, and B cell navie were significantly changed between normal and tumor group, while B cells memory, Plasma cells, T cells CD4 naive, T cells CD4 memory resting, T cells CD4 memory activated, T cells regulatory (Tregs), T cells gamma delta, Macrophages M1, Macrophages M2, Dendritic cells resting, Dendritic cells activated Eosinophils, and Neutrophils were not obviously altered between groups ([Figure 3](#F3){ref-type="fig"}, [Table 1](#T1){ref-type="table"}).

![The performance of CIBERSOST for estimating TIICs composition in HNC. **(A)** Relative proportions of 22 TIICs subpopulation in normal samples. **(B)** Relative proportions of 22 TIICs subpopulation in tumor samples. **(C)** Heat map of the 22 immune cell proportions.](fonc-09-01285-g0001){#F1}

![The stacked histogram shows the distribution of 22 immune cell infiltration between HNC adjacent tissues and tumor tissues, including total immune cells **(A)**, total T cells **(B)**, total B cells **(C)**, and total macrophages **(D)**.](fonc-09-01285-g0002){#F2}

![The Violin plot exhibits the difference between CIBERSOFT immune cell fractions between HNC adjacent tissues and tumor tissues.](fonc-09-01285-g0003){#F3}

###### 

Comparison of CIBERSORT immune fractions between HNC tumor tissues and adjacent tissues.

  **Immune cells subtype**       ***P* value**   **Normal means**   **Tumor means**   **logFC**
  ------------------------------ --------------- ------------------ ----------------- -----------
  B cells naive                  0.019           0.012169           0.005176          −1.2333
  B cells memory                 0.274           0.000872           8.02E-05          −3.4427
  Plasma cells                   0.454           0.078889           0.051193          −0.62387
  T cells CD8                    0.005           0.118383           0.0682            −0.79561
  T cells CD4 naive              0.657           0                  2.15E-05          Inf
  T cells CD4 memory resting     0.593           0.129735           0.116975          −0.14936
  T cells CD4 memory activated   0.145           0.046328           0.02998           −0.62785
  T cells follicular helper      0.03            0.042598           0.028291          −0.59047
  T cells regulatory (Tregs)     0.076           0.0362             0.02617           −0.46804
  T cells gamma delta            0.059           0.007368           0.00496           −0.57091
  NK cells resting               0.001           0.003734           0.02877           2.94596
  NK cells activated             0.028           0.030262           0.015923          −0.92639
  Monocytes                      0.047           0.019185           0.002836          −2.75803
  Macrophages M0                 \<0.001         0.127735           0.274906          1.10578
  Macrophages M1                 0.158           0.109336           0.094605          −0.20877
  Macrophages M2                 0.275           0.084117           0.097047          0.20629
  Dendritic cells resting        0.468           0.058007           0.054292          −0.0955
  Dendritic cells activated      0.293           0.019029           0.034497          0.858275
  Mast cells resting             0.001           0.056576           0.026052          −1.11881
  Mast cells activated           0.08            0.008166           0.030253          1.889414
  Eosinophils                    0.383           0.000171           0.00494           4.851694
  Neutrophils                    0.114           0.011142           0.004832          −1.20542

Form the [Figure 4](#F4){ref-type="fig"}, we can see that several highly positive relationship among LM22 immune cells in the HNC paired adjacent tumor samples were found, while mutual relationship among LM22 immune cells reduced in the tumor samples, such as Macrophages M2 was highly positive associated with Monocytes in the immune phenotype profiles in the TMC form the HNC paired adjacent tumor samples, while T cells regulatory (Tregs) was highly negatively related to T cells CD8 in the HNC tumor group. Thus, we hypothesized that alterations in the TME cell infiltration ratio directly reflect the difference in immunity between the two groups.

![Correlation matrix of all 22 immune proportions and immune cytolytic activity in the TCGA HNC cohort, including total samples **(A)**, normal samples **(B)** and tumor samples **(C)**.](fonc-09-01285-g0004){#F4}

In terms of clinical features, we can see that the fraction of T cells CD8, T cells follicular helper, T cells regulatory (Tregs) and T cells CD4 memory activated was higher in HNC HPV positive tissue than HNC HPV negative tissue, while NK cells resting, Macrophages M2, T cells CD4 memory resting, Macrophages M0 and Neutrophils were higher in the HNC HPV negative samples ([Figure 5](#F5){ref-type="fig"}, [Table 2](#T2){ref-type="table"}). T cells follicular helper was mainly observed in the early stage (G1/G2) of HNC ([Supplementary Figure 1](#SM1){ref-type="supplementary-material"}, [Supplementary Table 1](#SM3){ref-type="supplementary-material"}). Neutrophils and Macrophages M1 was associated with radiation therapy ([Supplementary Figure 2](#SM2){ref-type="supplementary-material"}, [Supplementary Table 2](#SM4){ref-type="supplementary-material"}). Therefore, these results demonstrated that aberrant immune infiltration and it\'s heterogeneous in HNC as a tightly regulated process might play important roles in the development of tumor, it has important clinical meanings.

![The difference between immune infiltration between HNC HPV positive and negative samples. **(A)** The total difference in immune cells infiltration. Box plot of the distribution of CIBERSORT *P* value for Macrophages M0 **(B)**, Macrophages M2 **(C)**, Neutrophils **(D)**, NK cells resting **(E)**, T cells CD4 memory activated **(F)**, T cells CD4 memory resting **(G)**, T cells CD8 **(H)**, T cells follicular helper **(I)** and T cells regulatory (Tregs) **(J)**, respectively.](fonc-09-01285-g0005){#F5}

###### 

Comparison of CIBERSORT immune fractions between HNC HPV positive patients and negative patients.

  **Immune cells**               **Normal means**   **Tumor means**   **logFC**   ***P* Value**
  ------------------------------ ------------------ ----------------- ----------- ---------------
  B cells memory                 2.17E−05           0.004647          7.741616    0.000231
  B cells naive                  0.014956           0.024706          0.724158    0.518213
  Dendritic cells activated      0.03191            0.021905          −0.54275    0.065003
  Dendritic cells resting        0.031514           0.02751           −0.19604    0.891241
  Eosinophils                    0.001891           0.000123          −3.94557    0.718216
  Macrophages M0                 0.247879           0.154108          −0.6857     0.009724
  Macrophages M1                 0.091053           0.110677          0.281571    0.359036
  Macrophages M2                 0.097167           0.069925          −0.47465    0.011035
  Mast cells activated           0.020716           0.008805          −1.23435    0.02111
  Mast cells resting             0.027321           0.031731          0.215875    0.178435
  Monocytes                      0.003497           0.001689          −1.04969    0.88545
  Neutrophils                    0.013373           0.001426          −3.22932    0.007963
  NK cells activated             0.015302           0.020886          0.448863    0.179469
  NK cells resting               0.0288             0.017236          −0.74063    0.038035
  Plasma cells                   0.060632           0.083056          0.454019    0.184296
  T cells CD4 memory activated   0.034592           0.053941          0.640956    0.028705
  T cells CD4 memory resting     0.144439           0.050991          −1.50214    3.15E-07
  T cells CD4 naive              1.00E-05           0                 Inf         0.563299
  T cells CD8                    0.071886           0.181113          1.3331      4.11E-07
  T cells follicular helper      0.031526           0.061919          0.973848    2.12E-05
  T cells gamma delta            0.003494           0.007961          1.187876    0.002974
  T cells regulatory (Tregs)     0.028021           0.065644          1.228147    0.000502

Identification of Prognostic LM22 Immune Cell Subtypes
------------------------------------------------------

The univariate Cox regression was conducted to screen the prognostic LM22 immune cell subsets in all tumor samples, and the results were shown that a total of 6 immune cell subsets (Eosinophils, T cells regulatory Tregs, Mast cells activated, B cells naïve and T cells follicular helper) was significantly correlated with OS when the *P*-value was less than 0.05 ([Figure 6A](#F6){ref-type="fig"}). B cells naive, T cells regulatory (Tregs), T cells follicular helper were associated with improved outcome. Mast cells activated and Eosinophils were associated with poorer outcome. Then, we conducted a Kaplan-Meier curve plot and log-rank test for the above-mentioned immune cell subsets, and the results are shown in [Figure 7](#F7){ref-type="fig"}. Eosinophils, Mast cells activated, B cells naïve and T cells follicular helper were significantly associated with OS with HNC patients.

![The prognostic associations of subsets of immune cells in Cox regression analysis. **(A)** Univariate Cox regression analysis. **(B)** Multivariate Cox regression analysis.](fonc-09-01285-g0006){#F6}

![The K-M survival analysis of four immune cells, including B cells naïve **(A)**, Eosinophils **(B)**, Mast cells activated **(C)**, and T cells follicular helper **(D)**.](fonc-09-01285-g0007){#F7}

Next, multivariate Cox proportional hazards regression analysis was further identified the prognostic LM22 immune cell subsets. The results indicated that T cells regulatory (Tregs) was associated with improved outcome ([Figure 6B](#F6){ref-type="fig"}). The ROC curves were used to evaluate the prognostic power of prognostic LM22 immune cell subsets. The AUC for prognostic LM22 immune cell subsets biomarkers prognostic model was shown in [Figure 8](#F8){ref-type="fig"}. In HNC, Dendritic cells activated, B cells naïve, Dendritic cells resting, Macrophages M0, Macrophages M2, Plasma cells, and T cells follicular helper had an AUC value of more than 0.550, and T cells follicular helper had the highest performance in the risk prediction of HNC patients. Detailed results are provided in [Table 3](#T3){ref-type="table"}.

![ROC curves of prognostic predictors built by the 22 immune cell subsets.](fonc-09-01285-g0008){#F8}

###### 

The AUC value for each immune cell.

  **Immune cells subtype**       **AUC**   **AUC; 95%CI**
  ------------------------------ --------- ----------------
  B cells naive                  0.568     0.503--0.628
  B cells memory                 0.489     0.283--0.856
  Plasma cells                   0.571     0.515--0.623
  T cells CD8                    0.534     0.478--0.588
  T cells CD4 naive              0.498     0.102--0.966
  T cells CD4 memory resting     0.534     0.479--0.587
  T cells CD4 memory activated   0.532     0.472--0.590
  T cells follicular helper      0.600     0.490--0.601
  T cells regulatory (Tregs)     0.548     0.493--0.604
  T cells gamma delta            0.477     0.368--0.684
  NK cells resting               0.510     0.449--0.568
  NK cells activated             0.525     0.472--0.606
  Monocytes                      0.484     0.37--0.583
  Macrophages M0                 0.551     0.449--0.560
  Macrophages M1                 0.532     0.480--0.585
  Macrophages M2                 0.550     0.501--0.612
  Dendritic cells resting        0.551     0.494--0.605
  Dendritic cells activated      0.553     0.491--0.612
  Mast cells resting             0.520     0.447--0.578
  Mast cells activated           0.536     0.463--0.624
  Eosinophils                    0.535     0.283--0.844
  Neutrophils                    0.534     0.465--0.600

Subsequently, the association between clinical features and LM22 immune cell subsets was performed to confirm the mutual relationship. After analysis, clinical covariates of HPV status, and gender, grade, race, radiation, age were significantly correlated with immune cell subclasses. However, clinical covariates of alcohol consumption, tobacco consumption, TNM stage, and neoadjuvant treatment are not significantly correlated with LM22 immune cell subsets ([Table 4](#T4){ref-type="table"}, [Figure 9](#F9){ref-type="fig"}). Among these clinical variables, radiation/grade/HPV was significantly associated with immune cell subclasses ([Figure 10](#F10){ref-type="fig"}).

###### 

Differences in pathway activities scored per cell by GSVA between HNC tumor and normal tissues.

  **Kegg pathway**                             **logFC**   **AveExpr**   ***t***    ***P* Value**   **adj.P.Val**   **B**
  -------------------------------------------- ----------- ------------- ---------- --------------- --------------- ----------
  HALLMARK_APICAL_JUNCTION                     −0.4025     0.010961      −5.25587   2.32E-07        6.26E-06        6.544336
  HALLMARK_HEME_METABOLISM                     −0.28374    −0.00808      −4.51909   8.03E-06        0.000108        3.184278
  HALLMARK_XENOBIOTIC_METABOLISM               −0.43824    0.012682      −4.39633   1.39E-05        0.000125        2.668925
  HALLMARK_KRAS_SIGNALING_DN                   0.238528    0.025281      4.240365   2.73E-05        0.000184        2.032894
  HALLMARK_ALLOGRAFT_REJECTION                 0.213846    0.003377      4.134352   4.28E-05        0.000231        1.612623
  HALLMARK_TNFA_SIGNALING_VIA_NFKB             −0.22983    −0.01298      −3.52174   0.000474        0.001829        −0.6217
  HALLMARK_KRAS_SIGNALING_UP                   −0.18953    0.007866      −3.36564   0.000832        0.002807        −1.13723
  HALLMARK_FATTY_ACID_METABOLISM               −0.30329    0.013411      −3.11011   0.001994        0.005981        −1.93318
  HALLMARK_INTERFERON_GAMMA_RESPONSE           0.175599    0.015616      2.771092   0.005828        0.015735        −2.89629
  HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION   −0.22674    0.017215      −2.18466   0.02945         0.06824         −4.30808
  HALLMARK_IL2_STAT5_SIGNALING                 0.116782    0.007269      2.17291    0.030329        0.06824         −4.33303
  HALLMARK_APICAL_SURFACE                      0.182865    0.000551      2.049396   0.041026        0.085208        −4.58742
  HALLMARK_SPERMATOGENESIS                     −0.13185    0.012642      −1.90605   0.057306        0.110518        −4.86433
  HALLMARK_ESTROGEN_RESPONSE_EARLY             −0.19236    0.023794      −1.72959   0.084417        0.15195         −5.1781
  HALLMARK_PEROXISOME                          0.132034    0.017083      1.48572    0.138082        0.233013        −5.56224
  HALLMARK_WNT_BETA_CATENIN_SIGNALING          0.139712    −0.01358      1.427229   0.154235        0.239908        −5.6458
  HALLMARK_P53_PATHWAY                         0.118958    −0.00521      1.407697   0.159939        0.239908        −5.67296
  HALLMARK_GLYCOLYSIS                          0.12231     −0.02451      1.114532   0.26567         0.362097        −6.03604
  HALLMARK_ANDROGEN_RESPONSE                   −0.09161    −0.01368      −1.08559   0.278264        0.362097        −6.06734
  HALLMARK_INFLAMMATORY_RESPONSE               −0.05291    0.00149       −1.07801   0.281631        0.362097        −6.0754
  HALLMARK_COMPLEMENT                          −0.05119    0.006593      −0.93414   0.35075         0.41205         −6.21774
  HALLMARK_ESTROGEN_RESPONSE_LATE              −0.09946    0.007701      −0.93365   0.351006        0.41205         −6.2182
  HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY     0.068331    −0.02072      0.803555   0.422095        0.474857        −6.32939
  HALLMARK_ANGIOGENESIS                        −0.06601    0.01222       −0.76906   0.442275        0.477657        −6.35609
  HALLMARK_MYOGENESIS                          −0.06866    −0.02249      −0.62445   0.532663        0.55315         −6.4553
  HALLMARK_NOTCH_SIGNALING                     −0.05143    −0.02244      −0.5239    0.600614        0.600614        −6.51217

![The correlation heat map of 22 immune cells and clinical features. The value in the space shows the correlation coefficient **(A)** and the *P* value **(B)**.](fonc-09-01285-g0009){#F9}

![The forest plots show the correlation between clinical characteristics and immune cell subsets. **(A)** Is Grade, **(B)** is for HPV status, and **(C)** is for Radiation.](fonc-09-01285-g0010){#F10}

Immune Cell Patterns in Molecular HNC Subclasses
------------------------------------------------

In order to uncover different immune cell population infiltration of TME in HNC, molecular classification of HNC was identified by performing unsupervised consensus clustering of all tumor samples. The optimal number of clusters was determined by the *K* value. After assessing the relative change in the area under the cumulative distribution function (CDF) curve and consensus heatmap, we selected a three-cluster solution (*K* = 3), which has no appreciable increase in the area under the CDF curve ([Figure 11](#F11){ref-type="fig"}). This finding resulted in 252 patients (59%) in cluster I, 38 patients (9%) in cluster II, and 138 patients (32%) in cluster III for the HNC cohort. The consensus matrix heatmap revealed the Cluster I and Cluster II, Cluster III well appeared individualized clusters in [Figure 12A](#F12){ref-type="fig"}. The sample of each cluster was shown in [Figure 12B](#F12){ref-type="fig"}. Moreover, clusters were associated with distinct patterns of survival in [Figure 12C](#F12){ref-type="fig"}. Compared with Cluster I and Cluster III, the patients who were classified as Cluster II had a good prognosis (*P* \< 0.001, log-rank test).

![The cluster counts evaluated. **(A)** CDF curve of *K* = 2--7. **(B)** The relative change in area under the CDF curve of *K* = 2--7.](fonc-09-01285-g0011){#F11}

![The cancer subtypes using SNFCC+ algorithm. **(A)** Log-rank test *p*-value for Kaplan--Meier survival analysis, **(B)** clustering heatmap visualizing the degree of the partitioning of the sample clusters, **(C)** average silhouette width representing the coherence of clusters.](fonc-09-01285-g0012){#F12}

Differentially Expressed Analysis of Genes/LM22 Immune Cell Fraction in Each HNC Subgroup
-----------------------------------------------------------------------------------------

The Kruskal-Wallis test was used to identify quantitative genes/LM22 immune cell significantly associated with each subtype. As for differential infiltration of LM22 immune cell in HNC TME, Cluster 1 was defined by high level of Macrophages M1 and Macrophages M2, Cluster 2 was enriched by B cells memory, B cells naive, Monocytes, Plasma cells, T cells CD8, T cells gamma delta, T cells regulatory (Tregs), NK cells activated and T cells follicular helper. While Cluster 3 was defined by the high level of Macrophages M0, Mast cells activated, Neutrophils, NK cells resting, and T cells CD4 memory resting ([Figure 13](#F13){ref-type="fig"}).

![Box plot depicting the association between immune cell subset and three clusters, depicted *P*-values are from the Kruskal-Wallis tests. **(A--O)** Is for B cells memory, B cells naïve, Macrophages M0, Macrophages M1, Macrophages M2, Mast cells activated, Monocytes, Neutrophils, NK cells activated, NK cells resting, Plasma cells, T cells CD4 memory resting, T cells CD8, T cells gamma delta, and T cells regulatory (Tregs), respectively.](fonc-09-01285-g0013){#F13}

In order to seek the molecular differences between HNC molecular subtypes and deriving subtype-specific biomarkers, the unpaired student *t*-test was used to identify quantitative genes significantly associated with each subtype. Gene differentially expressed analysis for unmatched subgroups was executed with the threshold of absolute log-fold change cutoff greater than 0.2 and FDR = 0.05. [Figure 14](#F14){ref-type="fig"} was shown by DEGs in concentric circles radiating among 3 Clusters. In subgroup 1 compared to subgroups 2, a total of 227 mRNAs (192 upregulated genes and 35 downregulated genes) were differentially expressed genes; In subgroup 1 compared to subgroups 3, a total of 242 differentially expressed mRNAs (14 upregulated genes and 228 down-regulated genes) were detected; In subgroup 2 compared to subgroups 3, a total of 333 differentially expressed mRNAs (41 upregulated genes and 292 down-regulated genes) were observed.

![Circular visualization of chromosomal positions, hierarchical clustering, connectivity and severity gradients (Left) and a volcano plot (Right) in HNC subgroups. **(A--C)** Is for cluster I vs. Cluster II, cluster I vs. cluster III and cluster II vs. Cluster III.](fonc-09-01285-g0014){#F14}

Gene Functional Annotation and Gene Ontology (GO) Enrichment Analysis, GSVA Analysis for DEGs to Identify Molecular Subtypes
----------------------------------------------------------------------------------------------------------------------------

In subgroup 1 compared to subgroup 2, a total of 533 GO terms of biological process, 8 GO terms of cellular component, and 53 GO terms of molecular function were identified to be significant (adjust *P*-value \< 0.05). In subgroup 1 compared to subgroups 3, A total of 692 GO terms of biological process, 19 GO terms of cellular component, and 66 GO terms of molecular function were identified to be significant. In subgroup 2 compared to subgroups 3, A total of 676 GO terms of biological process, 19 GO terms of cellular component, and 55 GO terms of molecular function were identified to be significant. Top GO terms included cytokine activity, immune/inflammatory response, and chemokine activity ([Figure 14](#F14){ref-type="fig"}). In addition, all the pathways that were yielded from the KEGG analysis were associated with immune response ([Figure 15](#F15){ref-type="fig"}).

![The GO and KEGG analysis for three HNC clusters. **(A--F)** Is for cluster I vs. Cluster II, cluster I vs. cluster III and cluster II vs. Cluster III.](fonc-09-01285-g0015){#F15}

Gene set variation analysis with three clusters was analyzed by GSVA package of R software. The number of enriched pathways progressively increased from Subtype 1 through Subtype 3. The most significant gene sets enriched were ordered by significance (false discovery rate (FDR) *P*- and adjusted *P*-values) and listed in [Table 4](#T4){ref-type="table"}. As shown in [Figure 16](#F16){ref-type="fig"}, several hallmark gene-sets, including "TNFA_SIGNALING_VIA_NFKB", "APICAL_JUNCTION", "EPITHELIAL_MESENCHYMAL_TRANSITION (EMT)," and "KRAS_SIGNALING_UP", "ANGIOGENESIS", were observed.

![The GSVA analysis for three HNC clusters.](fonc-09-01285-g0016){#F16}

Discussion {#s4}
==========

According to statistics from the National Central Cancer Registry of China ([@B21]) and the National Cancer Institute of USA ([@B22]), HSC is still the primary cancer disease worldwide. Especially in China, HNC is in the top ten causes of incidence rates and mortality in urban and rural regions in China ([@B21]). HNC is known for its rapid clinical progression and poor prognosis. The overall survival rate of HNC patients has not improved significantly over the past 20 years with the 5- year survival rate is \~45--50% ([@B23]). Therefore, HNC remains high-risk cancer affecting large numbers of people, threatening the lives of patients through local recurrence and metastatic cervical lymph nodes. Meanwhile, the potential molecular mechanism of HNC is not unknown and, more efforts should be used to this area to uncover the corresponding targeted therapy.

In current work, the CIBERSOFT was applied to evaluate the differential immune cell infiltration in paired HNC and adjacent normal tissue, and the results revealed that considerable difference in immune cell fraction occurred in both intra- and intergroup. Our work also uncovers the detail of infiltration of LM22 immune cell subsets in HNC that the proportions of macrophages account for more than 45%, in which 27% is M0, 9% is M2, and M1 make up 9%. In addition, T cells CD4 memory resting as the second proportion (12%) ([Table 1](#T1){ref-type="table"}). Compared to HNC and adjacent normal tissues, the proportions of Total Macrophage, Macrophages M0 and NK cells resting, total T cells, total B cells, T cells CD8, B cell navie, T cell follicular helper, NK cells activated, Monocyte, Mast cells resting produced statistical significance (*P* \< 0.05). The total T cells, total B cells, T cells CD8, B cell navie, T cell follicular helper, NK cells activated, Monocyte, and Mast cells resting were increased in adjacent normal tissues when compared to the HNC tissues. In contrast, Macrophages M0 and NK cells resting were decreased in adjacent normal tissues. The mechanisms behind the activation of NK cells resting and Macrophages M0, deactivation of B cells naïve, T cells gamma delta, NK cells activated, and Mast cells resting in HNC remain unclear. Macrophages cells and NK cells have been detected in HNC ([@B24], [@B25]), we hypothesize that tumor cell-derived metabolites such as oxidized natural polyamines might be responsible for activation of Macrophages and NK cells and deactivation of Mast cells.

The prognostic importance of immune cell infiltration has been identified for various solid tumor types ([@B26]--[@B28]). In univariate Cox analysis, we found that B cells naive, T cells regulatory (Tregs), T cells follicular helper were associated with improved outcome, while Mast cells activated and Eosinophils were associated with poorer outcome. Eosinophils and Mast cells activated were associated with poorer outcome. To the best of our knowledge, the T- cell immune response is the primary event in antitumor immunity ([@B29], [@B30]), especially in HNC ([@B31]). The T and B cells are present in immune cell infiltrates of HNC and the degree of tumor-infiltrating T and B cells correlated with improved survival of cancers ([@B32]). Nevertheless, Eosinophils has been recognized to correlate with angiogenesis and metastasis ([@B33]) and increased Eosinophils proportions are related to poor prognosis. This immune phenotype was in line with a previous study ([@B34]). In addition, several immune cells are associated with clinical outcome. T cells follicular helper correlated with an increase in the level of GRADE stage. Total T cells and Macrophages cells, Neutrophils are associated with HPV status. Neutrophils and Macrophages M1 are related to radiation therapy. Our data further validated these findings from the previous studies that specific immune cells were related to predicting clinical outcome ([@B35]--[@B37]).

HNC can be robustly divided into three subtypes by SNFCC+ method. And the results demonstrated that three subtype classifications were significantly associated with patients\' survival. Compared with Cluster I and Cluster III, the patients who were classified as Cluster II had a good prognosis. Compare with each Cluster of LM22 immune cell in HNC TME, Cluster I was defined by a high level of Macrophages cells infiltration, Cluster II was enriched by B cells infiltration and T cells infiltration. While Cluster III was defined by the high level of Mast cells infiltration, Neutrophils infiltration, and NK cells infiltration. Compared with each Cluster of DEGs, each cluster has its characteristic functional enrichment terms. Therefore, the three subtypes differed in overall survival, molecular characteristics.

In summary, our analysis of LM22 immune cell subsets using by CIBERSORT deconvolution algorithm provides the full information on immune cell landscape of HNC. Our finding has also uncovered a vital role in prediction for clinical outcome. In current work, this comprehensive assessment of LM22 immune cell infiltration models in TME shed light on how tumors respond to immunotherapy and might help clinicians to explore the development of the new drug.
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The difference of immune infiltration between HNC the early stage (G1/G2) and the late stage (G3/G4) samples. **(A)** The total difference in immune cells infiltration. **(B)** Box plot of the distribution of CIBERSORT *P* value for T cells follicular helper.
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###### 

The difference of immune infiltration between HNC with radiation therapy and without radiation therapy samples. **(A)** The total difference in immune cells infiltration. **(B,C)** Box plot of the distribution of CIBERSORT *P* value for Macrophages M2 and Neutrophils, respectively.
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Comparison of CIBERSORT immune fractions between grade G1/G2 and G3/G4.
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Comparison of CIBERSORT immune fractions between with and without radiation therapy.
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